HRT Financial’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $648K | Buy |
58,830
+41,340
| +236% | +$455K | ﹤0.01% | 1260 |
|
|
2025
Q1 | $156K | Buy |
+17,490
| New | +$156K | ﹤0.01% | 1848 |
|
|
2024
Q3 | – | Sell |
-153,424
| Closed | -$1.3M | – | 2910 |
|
|
2024
Q2 | $1.3M | Buy |
153,424
+22,035
| +17% | +$187K | 0.01% | 837 |
|
|
2024
Q1 | $1.18M | Buy |
131,389
+53,170
| +68% | +$477K | 0.01% | 778 |
|
|
2023
Q4 | $879K | Sell |
78,219
-61,679
| -44% | -$693K | 0.01% | 978 |
|
|
2023
Q3 | $1.21M | Sell |
139,898
-161,182
| -54% | -$1.39M | 0.01% | 794 |
|
|
2023
Q2 | $3.12M | Buy |
+301,080
| New | +$3.12M | 0.03% | 419 |
|
|
2022
Q4 | – | Sell |
-49,596
| Closed | -$502K | – | 2913 |
|
|
2022
Q3 | $502K | Buy |
49,596
+33,840
| +215% | +$343K | 0.01% | 1437 |
|
|
2022
Q2 | $142K | Sell |
15,756
-19,533
| -55% | -$176K | ﹤0.01% | 2278 |
|
|
2022
Q1 | $337K | Sell |
35,289
-2,264
| -6% | -$21.6K | ﹤0.01% | 1938 |
|
|
2021
Q4 | $414K | Buy |
+37,553
| New | +$414K | ﹤0.01% | 1825 |
|
|
2021
Q3 | – | Sell |
-16,150
| Closed | -$234K | – | 3491 |
|
|
2021
Q2 | $234K | Buy |
16,150
+6,320
| +64% | +$91.6K | ﹤0.01% | 2204 |
|
|
2021
Q1 | $200K | Buy |
+9,830
| New | +$200K | ﹤0.01% | 2084 |
|
|
2020
Q4 | – | Sell |
-21,083
| Closed | -$311K | – | 2365 |
|
|
2020
Q3 | $311K | Buy |
21,083
+4,155
| +25% | +$61.3K | 0.01% | 1043 |
|
|
2020
Q2 | $355K | Buy |
+16,928
| New | +$355K | 0.01% | 813 |
|